GSK PLC-SPON ADR
GSK · NYSE
Updated at 2026-10-13 13:50:58
- Today's High
- $47.15
- Today’s Low
- $46.75
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $46.70
- Previous Close
- $46.92
- Volume
- 10.34M
- Market Cap
- $74.86B
- P/E Ratio
- 15.52X
- EPS
- $1.18
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- DRUG MANUFACTURERS - GENERAL
- Headquarters
- 79 NEW OXFORD STREET, LONDON, UNITED KINGDOM, WC1A 1DG
- Country
- GB
- Listing Date
- 1972-05-22
- Fiscal Year End
- December
- Shares Outstanding
- 4.04B
- CIK
- 0001131399
- Website
- www.gsk.com
GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines, over-the-counter drugs and health-related consumer products in the UK, US and internationally. The company is headquartered in Brentford, the United Kingdom.
Financial Metrics
Revenue
2026-06-30
$8.4B
2026-03-31
$7.62B
2025-12-31
$8.61B
2025-09-30
$8.54B
Operating Expenses
2026-06-30
$5.66B
2026-03-31
$3.46B
2025-12-31
$4.45B
2025-09-30
$3.69B
Net Income
2026-06-30
$435M
2026-03-31
$1.73B
2025-12-31
$636M
2025-09-30
$2.01B
Net Profit Margin
2026-06-30
5.17%
2026-03-31
22.76%
2025-12-31
7.37%
2025-09-30
23.55%
Earnings Per Share
2026-06-30
$1.36
2026-03-31
$1.26
2025-12-31
$0.70
2025-09-30
$1.46
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$760.8M
2026-03-31
$2.77B
2025-12-31
$1.9B
2025-09-30
$3.36B
Effective Tax Rate
2026-06-30
-56.21%
2026-03-31
14.22%
2025-12-31
23.47%
2025-09-30
12.7%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $8.4B | $7.62B | $8.61B | $8.54B |
| Operating Expenses | $5.66B | $3.46B | $4.45B | $3.69B |
| Net Income | $435M | $1.73B | $636M | $2.01B |
| Net Profit Margin | 5.17% | 22.76% | 7.37% | 23.55% |
| Earnings Per Share | $1.36 | $1.26 | $0.70 | $1.46 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $760.8M | $2.77B | $1.9B | $3.36B |
| Effective Tax Rate | -56.21% | 14.22% | 23.47% | 12.7% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.